Related Experiment Video
Updated: May 25, 2025

Transplantation of Human Induced Pluripotent Stem Cell-Derived Microglia in Immunocompetent Mice Brain via Non-Invasive Transnasal Route
Published on: May 31, 2022
Integration and functionality of human iPSC-derived microglia in a chimeric mouse retinal model.
Chun Tang1,2, Qi-Qi Zhou1,2, Xiu-Feng Huang3
1The State Key Laboratory of Ophthalmology, Optometry and Visual Science, Wenzhou Medical University, Wenzhou, 325027, China.
Researchers developed a novel ex vivo model using human microglia in mouse retinal explants to study retinal diseases. This model successfully integrates human microglia, enabling the study of their function and response to degeneration, advancing therapeutic development.
Area of Science:
- Neuroscience
- Immunology
- Stem Cell Biology
Background:
- Microglia are crucial for central nervous system homeostasis and neuroinflammation.
- Rodent models have limitations in accurately representing human microglia for retinal disease research.
Purpose of the Study:
- To develop a novel ex vivo chimeric model for studying human microglia in the retinal context.
- To overcome limitations of current animal models in human microglia research.
Main Methods:
- Elimination of endogenous mouse microglia using PLX5622.
- Transplantation of human induced pluripotent stem cell-derived microglia (hiPSC-microglia) into mouse retinal explants.
- Quantification of xenotransplanted microglia (xMG) integration and function (proliferation, phagocytosis).
- Transcriptomic analysis using single-cell RNA sequencing (scRNA-seq).
Main Results:
- Successful migration and integration of human microglia (xMG) into mouse retinal explants (>86% integration).
- xMG maintained homeostatic morphology and key functions including proliferation, immune response, and synaptic pruning over 14 days.
- scRNA-seq revealed an in vivo-like phenotype shift in xMG compared to monoculture hiPSC-microglia.
- xMG showed activation and migration towards degenerated photoreceptors in a retinal degeneration model.
Conclusions:
- The developed ex vivo model is a powerful platform for studying human microglia in retinal diseases.
- This model offers significant insights for advancing research and developing therapeutic strategies for retinal degenerative diseases.
- Future applications include using patient-derived iPSCs to investigate disease-specific microglial behaviors and pathogenesis.
More Related Videos
06:24Generation of Human Microglia to Combine Them with Retinal Organoids for Improved Disease Modeling
Published on: July 26, 2024
11:19Human Microglia-like Cells: Differentiation from Induced Pluripotent Stem Cells and In Vitro Live-cell Phagocytosis Assay using Human Synaptosomes
Published on: August 18, 2022